Arman Shahriar, MD
@armanashahriar
🇺🇸 🇮🇷 🇪🇨∙PGY-3 @MedChiefs∙via @umnmedschool @umnbme @bostonsci
⚽️ enthusiast
ID: 887301215872331776
18-07-2017 13:21:09
374 Tweet
410 Followers
355 Following
        
        
        Our curious MedChiefs residents came to me, unsolicited, with some thoughts on ENACT-HF that they put into a Letter-to-the-Editor Circ: Heart Failure Led to a great HF Journal Club on this trial and use of urine-Na. Great work Arman Shahriar, MD & Tess Allan! ahajournals.org/doi/10.1161/CI…
        How to Ace your United Healthcare Interview UnitedHealthcare
        PBMs say they don't set drug prices, but their own data disagrees. For example, Medicare data for CVS Health plans show them setting 597 different prices for imatinib that are as low as $2,658 and as high as $8,199. Mark Cuban sells the same drug for $40. 46brooklyn.com/research/07222…
                        
                    
                    
                    
                
        
        
        
        
        Another great Study of the Week by John Mandrola, MD. If you're not reading these, you're doing something terribly wrong.🙂 The EARLY TAVR Trial Exposes the Main Tension in Medical Science open.substack.com/pub/sensibleme…
        
        
        
        Arman Shahriar, MD European Society of Cardiology Journals Adam Cifu A pleasure to work with you on this Arman Shahriar, MD and Adam Cifu, and thanks to European Society of Cardiology Journals for publishing!
        Very proud of this paper. Kudos to Arman Shahriar, MD for doing ALL the heavy lifting. Jonathan Paul Endovascular management of intermediate-risk pulmonary embolism: evidence, outstanding questions, drivers of utilization, and the horizon academic.oup.com/ehjopen/articl…